Pharmaceutical / Drug Definition :
Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.
Ceftazidime (Ceftazidime Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Ceftazidime (Ceftazidime Suppliers)
- Processors Ceftazidime
- Repackers Ceftazidime
- Relabelers Ceftazidime
- Exporters Ceftazidime
- Importers Ceftazidime
For more information about Ceftazidime, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.